Samarium153-EDTMP data

CYTO (Princeton, N.J.) presented results of a Phase II European trial showing that a single injection relieved pain in 70 percent of 74 patients, according to self-assessments and physician examination.

Patients had a variety of cancer, primarily prostate and breast, that had spread to bone. Relief lasted for four months. ...